Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Huilan Zeng
Institutions:
Guangzhou University of Chinese Medicine,
Guangdong Provincial Hospital of Chinese Medicine
Observed institutions:
Guangzhou University of Chinese Medicine,
Sun Yat-sen University,
Guangdong Provincial Hospital of Chinese Medicine,
Sun Yat-sen University Cancer Center,
State Key Laboratory of Oncology in South China
ORCID:
0000-0003-1701-3660
Observed ORCIDs:
0000-0003-1701-3660,
0009-0001-3274-4296
OpenAlex ID:
A5008624944
Cholesterol Efflux Drives the Generation of Immunosuppressive Macrophages to Promote the Progression of Human Hepatocellular Carcinoma
2023
·
Zhixiong Li
, Yongchun Wang
, et al.
·
Cancer Immunology Research
·
37
Inflammation-Based Scores Predict Responses to PD-1 Inhibitor Treatment in Intrahepatic Cholangiocarcinoma
2022
·
Zhenyun Yang
, Deyao Zhang
, et al.
·
Journal of Inflammation Research
·
36
PDF
Liver Tumor Markers, HALP Score, and NLR: Simple, Cost-Effective, Easily Accessible Indexes for Predicting Prognosis in ICC Patients after Surgery
2022
·
Deyao Zhang
, Huilan Zeng
, et al.
·
Journal of Personalized Medicine
·
31
PDF
Levels of pretreatment serum lipids predict responses to PD-1 inhibitor treatment in advanced intrahepatic cholangiocarcinoma
2023
·
Zhenyun Yang
, Deyao Zhang
, et al.
·
International Immunopharmacology
·
19
A Nomogram Based on Preoperative Lab Tests, BMI, ICG-R15, and EHBF for the Prediction of Post-Hepatectomy Liver Failure in Patients with Hepatocellular Carcinoma
2022
·
Deyao Zhang
, Yangxun Pan
, et al.
·
Journal of Clinical Medicine
·
19
PDF
Tenofovir vs. Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma after Radiofrequency Ablation
2022
·
Zili Hu
, Huilan Zeng
, et al.
·
Viruses
·
14
PDF
Comparable Clinical Outcomes Between Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy Combined with Tyrosine Kinase Inhibitors and PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma
2023
·
Teng Long
, Zhoutian Yang
, et al.
·
Journal of Hepatocellular Carcinoma
·
11
PDF
Sequential vs. concurrent systemic therapies in combination with FOLFOX-HAIC for locally advanced hepatocellular carcinoma: a single-center, real-world cohort study
2024
·
Liyang Sun
, Zhiwen Hu
, et al.
·
BMC Cancer
·
10
PDF
Cholesterol and C-reactive protein prognostic score predicted prognosis of immune checkpoint inhibitors based interventional therapies for intermediate-to-advanced hepatocellular carcinoma patients
2023
·
Huilan Zeng
, Deyao Zhang
, et al.
·
International Immunopharmacology
·
6
A Systemic Inflammation Response Score for Prognostic Prediction in Hepatocellular Carcinoma Patients After Hepatectomy
2022
·
Deyao Zhang
, Lanqing Huo
, et al.
·
Journal of Inflammation Research
·
3
PDF
Continuous adjuvant therapy with the same regimen improves survival following conversion therapy and hepatectomy in initially unresectable hepatocellular carcinoma: a multicenter retrospective study
2023
·
Zhenyun Yang
, Xiaohui Wang
, et al.
·
HepatoBiliary Surgery and Nutrition
·
1
Pathological Complete Response and Successful Conversion Hepatectomy in Initially Unresectable Giant Hepatocellular Carcinoma Following Triple Therapy With HAIC , Bevacizumab, and Tislelizumab: A Case Report
2026
·
Qing Ye
, Jiamin Wang
, et al.
·
Clinical Case Reports
PDF
Supplementary Data from Cholesterol Efflux Drives the Generation of Immunosuppressive Macrophages to Promote the Progression of Human Hepatocellular Carcinoma
2025
·
Zhixiong Li
, Yongchun Wang
, et al.
A convenient and self-adjustable laparoscopic intracorporeal pringle maneuver using He’s belt
2025
·
Huilan Zeng
, Jiaqiang Mo
, et al.
·
BMC Surgery
PDF
Supplementary Data from Cholesterol efflux drives the generation of immunosuppressive macrophages to promote the progression of human hepatocellular carcinoma
2024
·
Zhixiong Li
, Yongchun Wang
, et al.
Supplementary Data from Cholesterol efflux drives the generation of immunosuppressive macrophages to promote the progression of human hepatocellular carcinoma
2024
·
Zhixiong Li
, Yongchun Wang
, et al.
Supplementary Data from Cholesterol Efflux Drives the Generation of Immunosuppressive Macrophages to Promote the Progression of Human Hepatocellular Carcinoma
2023
·
Zhixiong Li
, Yongchun Wang
, et al.
Data from Cholesterol Efflux Drives the Generation of Immunosuppressive Macrophages to Promote the Progression of Human Hepatocellular Carcinoma
2023
·
Zhixiong Li
, Yongchun Wang
, et al.
Data from Cholesterol Efflux Drives the Generation of Immunosuppressive Macrophages to Promote the Progression of Human Hepatocellular Carcinoma
2023
·
Zhixiong Li
, Yongchun Wang
, et al.
Incomplete ablation vs. complete ablation for solitary hepatocellular carcinoma ≤5 cm: the 10-year survival analysis
2023
·
Mingfang Zhang
, Zhoutian Yang
, et al.
·
HepatoBiliary Surgery and Nutrition
Show more works
View as search
Works count:
20
Citation count:
187
H-index:
8
I10-index:
8
Year
Topic
Type